In December at the San Antonio Breast Cancer Symposium, we presented exciting Phase 2 results with sacituzumab govitecan, which were met with enthusiasm by clinicians around the world. The strength of the clinical profile of the sacituzumab govitecan program was recognized by Royalty Pharma,…
News
- Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update
- San Antonio Airport Adds Non-Stop Service to Raleigh-Durham
Tom Bartlett, deputy aviation director for the city, said Raleigh-Durham and San Antonio have a strong military connection, “and there's (information technology), and biosciences and other businesses. There's quite a large group of travelers right now.” With the addition of Raleigh-Durham,…
- Business Highlights
LOS ANGELES (AP) — The struggling Los Angeles Times found a local savior in a biotech billionaire willing to buy the storied newspaper from a corporation half a continent away, but the change of ownership brings questions and uncertainty. Tronc Inc. announced Wednesday that Dr. Patrick…
- San Antonio airport gets nonstop Frontier Airlines route to North Carolina's Research Triangle
Frontier Airlines will launch a nonstop route from the San Antonio International Airport to North Carolina in April — beefing up the low-cost airline's presence at the airport as well as the city's access to vibrant technology and biotech companies in the Research Triangle. Frontier's service…
- UMKC announces new Chancellor
“Mauli is a beloved member of the San Antonio community who has earned admiration and respect from the university community, the business community and civic ... Dr. Agrawal has a long history in academia, focusing on biomedical topics such as orthopedic and cardiovascular biomaterials/implants…